Latest Macula Stories
DEAR DR. DONOHUE: Everything I read or hear about macular degeneration is always about dry macular degeneration. I happen to have the wet kind, and would like to know what its treatments are. I've heard that vitamins work. Do they? Thank you. - T.R.
WASHINGTON - What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing $60 per treatment and the other $2,000? In the case of Genentech Inc., nothing.
The Retina Group of New York will present an educational meeting regarding age-related macular degeneration especially designed for seniors. The lecture will be held at the Farmingdale Public Library at 116 Merritts Road, Farmingdale, NY 11735, 1:00 to 2:00 p.m. on Friday, August 15.
DEAR DR. DONOHUE: My sister, who is only 54, has been diagnosed with macular degeneration in both eyes - the dry kind. We have been unable to find anything about it. We did find that the dry kind is the worse kind, and that laser treatments don't work for it.
DEAR DR. DONOHUE: I am a former athlete with 25 years of soccer playing, eight years of ballet, six years of field hockey, 12 high- school varsity letters and a four-year, full-ride athletic scholarship to college.
ATLANTA, June 26 /PRNewswire/ -- Alimera Sciences, Inc., a privately held biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported the interim month three safety and efficacy results from the first human pharmacokinetic (PK) study of Medidur(TM) FA, which Alimera Sciences intends to market under the tradename Iluvien(TM), if approved by the U.S.
SAN DIEGO, June 19 /PRNewswire/ -- Sydney company, Seagull Technology Pty Ltd, has developed a non-invasive drug delivery device that reduces the risks associated with the treatment of Australia's leading cause of blindness and severe vision loss -- Age Related Macular Degeneration (AMD), a degenerative disease of the retina which affects one in seven people over the age of 50.
For years, there has been much research and development to improve poor eyesight, including the use of scratch-resistant and radiation-blocking lenses. Now, a revolutionary product for eye correction focuses specifically on the needs of those in working environments, called the Eye Saver Easy Reading Light Bulb.
- totally perplexed and mixed up.
More Images (2 images) »